UBXD2 Antibody [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-05991F
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunocytochemistry/ Immunofluorescence, Immunohistochemistry-Paraffin
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for UBXD2 Antibody [FITC]
Immunogen
Produced in rabbits immunized with E. coli-derived Human UBXD2 fragment.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for UBXD2 Antibody [FITC]
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen and protein A Affinity-purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: UBXD2
Alternate Names
Erasin, FLJ23318, KIAA0242KIAA2042, UBX domain containing 2, UBX domain protein 4, UBX domain-containing 1, UBX domain-containing 2, UBX domain-containing protein 2, UBX domain-containing protein 4, UBXD2, UBXDC1
Gene Symbol
UBXN4
Additional UBXD2 Products
Product Documents for UBXD2 Antibody [FITC]
Product Specific Notices for UBXD2 Antibody [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...